Clinical Trial Update: Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS) [Phase 3]

View source ↗

Summary

Phase 3 trial investigating adding alirocumab to statin therapy for asymptomatic intracranial atherosclerotic stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Atherosclerosis

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Intracranial Atherosclerosis, Atherosclerotic Plaque | Phase 3 | Status: UNKNOWN